Neuroprotection afforded by adenosine A2A receptor blockade is modulated by corticotrophin-releasing factor (CRF) in glutamate injured cortical neurons

Journal of Neurochemistry

Volumn 123, Issue 6, 2012, Pages 1030-1040

  Valadas, Jorge S ^a   Batalha, Vânia L ^a   Ferreira, Diana G ^a   Gomes, Rui ^a,b   Coelho, Joana E ^a   Sebastião, Ana M ^a   Diógenes, Maria José ^a   Lopes, Luísa V ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

adenosine A2A receptors; corticotrophin releasing factor (CRF); CRF1R; CRF2R; hippocampus; neuroprotection

Indexed keywords

ADENOSINE A2A RECEPTOR; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; GLUTAMIC ACID; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 2;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EXCITOTOXICITY; GENE EXPRESSION; GLIA CELL; IN VITRO STUDY; NERVE CELL CULTURE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BLOCKING;

ADENOSINE A2 RECEPTOR ANTAGONISTS; ANIMALS; CEREBRAL CORTEX; CORTICOTROPIN-RELEASING HORMONE; GLUTAMIC ACID; NEURAL INHIBITION; NEURONS; NEUROPROTECTIVE AGENTS; PRIMARY CELL CULTURE; PYRIMIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; TRIAZOLES;

RATTUS;

EID: 84870600931     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12050     Document Type: Article

References (53)

1. Andiné P., Rudolphi K. A., Fredholm B. B., and, Hagberg H., (1990) Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia. Br. J. Pharmacol. 100, 814-818.
2. Ankarcrona M., Dypbukt J. M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S. A., and, Nicotera P., (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973.
3. Batalha V. L., Pego J. M., Fontinha B. M., Costenla A. R., Valadas J. S., Baqi Y., Radjainia H., Müller C. E., Sebastião A. M., and, Lopes L. V., (2012) Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation. Mol. Psychiatry. doi: 10.1038/mp.2012.8. (Epub ahead of print)
4. Bayatti N., Hermann H., Lutz B., and, Behl C., (2005) Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system. Endocrinology 146, 1205-1213.
5. Bittencourt J. C., Vaughan J., Arias C., Rissman R., and, a, Vale, W.W. & Sawchenko P.E., (1999) Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J. Comp. Neurol. 415, 285-312.
6. Blank T., Nijholt I., Grammatopoulos D. K., Randeva H. S., Hillhouse E. W., and, Spiess J., (2003) Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J. Neurosci. 23, 700-707.
7. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., and, Lipton S. A., (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl Acad. Sci. USA 92, 7162-7166.
8. Canas P. M., Porciuncula L. O., Cunha G. M., Silva C. G., Machado N. J., Oliveira J. M., Oliveira C. R., and, Cunha R. A., (2009) Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J. Neurosci. 29, 14741-14751.
9. Chalmers D. T., Lovenberg T. W., and, De Souza E. B., (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15, 6340-6350.
10. Chen F. M., Bilezikjian L. M., Perrin M. H., Rivier J., and, Vale W., (1986) Corticotropin releasing factor receptor-mediated stimulation of adenylate cyclase activity in the rat brain. Brain Res. 386, 49-57.
11. Chen R., Lewis K., and, a, Perrin, M.H. & Vale W.W., (1993) Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl Acad. Sci. USA 90, 8967-8971.
12. Chen J. F., Huang Z., Ma J., Zhu J., Moratalla R., Standaert D., Moskowitz M. A., Fink J. S., and, Schwarzschild M. A., (1999) A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19, 9192-9200.
13. Chen Y., Bender R. A., Frotscher M., and, Baram T. Z., (2001) Novel and transient populations of corticotropin-releasing hormone-expressing neurons in developing hippocampus suggest unique functional roles: a quantitative spatiotemporal analysis. J. Neurosci. 21, 7171-7181.
14. Chen Y, Brunson KL, Adelmann G, Bender RA, Frotscher M, and, Baram TZ., (2004a) Hippocampal corticotropin releasing hormone: pre- and postsynaptic location and release by stress. Neuroscience 126, 533-540.
15. Chen X. Q., Du J. Z., and, Wang Y. S., (2004b) Regulation of hypoxia-induced release of corticotropin-releasing factor in the rat hypothalamus by norepinephrine. Regul. Pept. 119, 221-228.
16. Choi D. W., Maulucci-Gedde M., and, Kriegstein A. R., (1987) Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7, 357-368.
17. Cunha G. M., Canas P. M., Oliveira C. R., and, Cunha R. A., (2006) Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress. Neuroscience 141, 1775-1781.
18. Dall'Igna O. P., Porciuncula L. O., Souza D. O., Cunha R. A., and, Lara D. R., (2003) Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity. Br. J. Pharmacol. 138, 1207-1209.
19. Dias R. B., Ribeiro J. A., and, Sebastião A. M., (2012) Enhancement of AMPA currents and GluR1 membrane expression through PKA-coupled adenosine A(2A) receptors. Hippocampus 22, 276-291.
20. Elliott-Hunt C. R., Kazlauskaite J., Wilde G. J., Grammatopoulos D. K., and, Hillhouse E. W., (2002) Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus. J. Neurochem. 80, 416-425.
21. Estus S., Tucker H. M., van Rooyen C., Wright S., Brigham E. F., Wogulis M., and, Rydel R. E., (1997) Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant "apoptotic" pattern of gene induction. J. Neurosci. 17, 7736-7745.
22. Fischman A. J., and, Moldow R. L., (1982) Extrahypothalamic distribution of CRF-like immunoreactivity in the rat brain. Peptides 3, 149-153.
23. Fox M. W., Anderson R. E., and, Meyer F. B., (1993) Neuroprotection by corticotropin releasing factor during hypoxia in rat brain. Stroke 24, 1072-1075.
24. Fredholm B. B., AP I. J., Jacobson K. A., Klotz K. N., and, Linden J., (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527-552.
25. Fredholm B. B., Chen J. F., Cunha R. A., Svenningsson P., and, Vaugeois J. M., (2005) Adenosine and brain function. Int. Rev. Neurobiol. 63, 191-270.
26. Grammatopoulos D. K., Randeva H. S., Levine M. A., Kanellopoulou K. A., and, Hillhouse E. W., (2001) Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J. Neurochem. 76, 509-519.
27. Gulyas J., Rivier C., Perrin M., Koerber S. C., Sutton S., Corrigan A., Lahrichi S. L., and, Craig, a G., Vale, W. & Rivier, J., (1995) Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc. Natl Acad. Sci. USA 92, 10575-10579.
28. Kemppainen S., Rantamäki T., Jerónimo-Santos A., et al,. (2012) Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice. Neurobiol. Aging 33, 1122-1139.
29. Latini S., and, Pedata F., (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79, 463-484.
30. Leonard A. S., and, Hell J. W., (1997) Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites. J. Biol. Chem. 272, 12107-12115.
31. Leveille F., El Gaamouch F., Gouix E., Lecocq M., Lobner D., Nicole O., and, Buisson A., (2008) Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J. 22, 4258-4271.
32. Lipton S. A., and, Rosenberg P. A., (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-622.
33. Lopes L. V., Cunha R. A., Kull B., Fredholm B. B., and, Ribeiro J. A., (2002) Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Neuroscience 112, 319-329.
34. Lovenberg T. W., Liaw C. W., Grigoriadis D. E., Clevenger W., Chalmers D. T., De Souza E. B., and, Oltersdorf T., (1995) Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl Acad. Sci. USA 92, 836-840.
35. Lowry O. H., Rosebrough N. J., Farr A. L., and, Randall R. J., (1951) Protein measurement with the Folin Phenol Reagent, J. Biol. Chem. 193, 265-275.
36. Melani A., Gianfriddo M., Vannucchi M. G., Cipriani S., Baraldi P. G., Giovannini M. G., and, Pedata F., (2006) The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Res. 1073-1074, 470-480.
37. de Mendonça A., Sebastião A. M., and, Ribeiro J. A., (2000) Adenosine: does it have a neuroprotective role after all? Brain Res. Brain Res. Rev. 33, 258-274.
38. Monopoli A., Lozza G., Forlani A., Mattavelli A., and, Ongini E., (1998) Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. NeuroReport 9, 3955-3959.
39. Nicotera P., Leist M., and, Manzo L., (1999) Neuronal cell death: a demise with different shapes. Trends Pharmacol. Sci. 20, 46-51.
40. Pedersen W. A., McCullers D., Culmsee C., Haughey N. J., Herman J. P., and, Mattson M. P., (2001) Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Neurobiol. Dis. 8, 492-503.
41. Pedersen W. A., Wan R., Zhang P., and, Mattson M. P., (2002) Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I. J. Neurosci. 22, 404-412.
42. Popoli P., Frank C., Tebano M. T., Potenza R. L., Pintor A., Domenici M. R., Nazzicone V., Pèzzola A., and, Reggio R., (2003) Modulation of glutamate release and excitotoxicity by adenosine A2A receptors. Neurology 61, S69-S71.
43. Radulovic J., Rühmann A., Liepold T., and, Spiess J., (1999) Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J. Neurosci. 19, 5016-5025.
44. Rebola N., Porciuncula L. O., Lopes L. V., Oliveira C. R., Soares-da-Silva P., and, Cunha R. A., (2005a) Long-term effect of convulsive behavior on the density of adenosine A1 and A 2A receptors in the rat cerebral cortex. Epilepsia 46 (Suppl 5), 159-165.
45. Rebola N., Rodrigues R. J., Oliveira C. R., and, Cunha R. A., (2005b) Different roles of adenosine A1, A2A and A3 receptors in controlling kainate-induced toxicity in cortical cultured neurons. Neurochem. Int. 47, 317-325.
46. Rissman R. A, Lee K.-F., Vale W., and, Sawchenko P. E., (2007) Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation. J. Neurosci. 27, 6552-6562.
47. Swanson L. W., Sawchenko P. E., Rivier J., and, Vale W. W., (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat barin: an immunohistochemical study. Neuroendocrinology 36, 165-186.
48. Szabadfi K., Atlasz T., Reglodi D., Kiss P., Dányádi B., Fekete E. M., Zorrilla E. P., Tamás A., Szabó K., and, Gábriel R., (2009) Urocortin 2 protects against retinal degeneration following bilateral common carotid artery occlusion in the rat. Neurosci. Lett. 455, 42-45.
49. Tamura Y., Sato Y., Yokota T., Akaike A., Sasa M., and, Takaori S., (1993) Ifenprodil prevents glutamate cytotoxicity via polyamine modulatory sites of N-methyl-D-aspartate receptors in cultured cortical neurons. J. Pharmacol. Exp. Ther. 265, 1017-1025.
50. Tan S.-E., Wenthold J., and, Soderlingl R., (1994) Phosphorylation of AMPA-type glutamate receptors by calcium / protein kinase II and protein kinase C in cultured hippocampal neurons. J. Neurosci. 14, 1123-1129.
51. Towbin H., Staehelin T., and, Gordon J., (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA 76, 4350-4354.
52. Vale W., Spiess J., Rivier C., and, Rivier J., (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213, 1394-1397.
53. Vaughan J., Donaldson C., Bittencourt J., et al,. (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin- releasing factor. Nature 378, 287-292.